Biofrontera AG (ETR:B8FK)
Germany · Delayed Price · Currency is EUR 2.410
-0.080 (-3.21%)
Aug 26, 2026, 5:44 PM CET
Biofrontera AG Market Cap
Biofrontera AG has a market cap or net worth of €14.89 million as of August 26, 2026. Its market cap has decreased by -11.87% in one year.
Market Cap
14.89M
Enterprise Value
11.14M
Revenue
13.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.41
ChartMarket Cap Chart
Since October 31, 2006, Biofrontera AG's market cap has decreased from 38.05M to 14.89M, a decrease of -60.87%. That is a compound annual growth rate of -4.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 14.89M | 0.41% |
| Dec 30, 2025 | 14.83M | 13.49% |
| Dec 30, 2024 | 13.07M | -48.94% |
| Dec 29, 2023 | 25.59M | -73.70% |
| Dec 30, 2022 | 97.31M | 15.92% |
| Dec 30, 2021 | 83.94M | -42.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 60.17B |
| Bayer Aktiengesellschaft | 47.63B |
| Siemens Healthineers AG | 44.96B |
| Fresenius SE & Co. KGaA | 25.93B |
| Pentixapharm Holding AG | 46.59M |
| MeVis Medical Solutions AG | 43.32M |
| NanoRepro AG | 23.33M |
| aap Implantate AG | 20.31M |